A multicentre study of the early bactericidal activity of anti-tuberculosis drugs

Journal of Antimicrobial Chemotherapy

Volumn 45, Issue 6, 2000, Pages 859-870

  Sirgel, F A ^a   Donald, P R ^b   Odhiambo, J ^c   Githui, W ^c   Umapathy, K C ^d   Paramasivan, C N ^d   Tam, C M ^f   Kam, K M ^f   Lam, C W ^f   Sole, K M ^e   Mitchison, D A ^e   Botha, F J ^f   Parkin, D P ^f   Van De Wal, B W ^f   Seifart, H I ^f   Venter, A ^a   Morris, P ^f   Talent, J ^f   Chakaya, J M ^f   Juma, E ^f   Gicheha, C ^f   Kimari, J ^f   Karimi, F ^f   Mumbi, P ^f   Kimwomi, J ^f   Prabhakar, R ^d   Herbert, D ^d   Hampuranan, K J ^d   Thyagarajan, K ^d   Chan, S L ^f   more..

^a SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^b STELLENBOSCH UNIVERSITY   (South Africa)

^c KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^d NATIONAL INSTITUTE FOR RESEARCH IN TUBERCULOSIS   (India)

^e ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^f St George's Hospital Medical School ^*

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; OFLOXACIN; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; BACTERICIDAL ACTIVITY; CLINICAL TRIAL; COLONY FORMING UNIT; FEMALE; HONG KONG; HUMAN; INDIA; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MYCOBACTERIUM TUBERCULOSIS; SOUTH AFRICA; SPUTUM ANALYSIS; TIME;

EID: 0034038617     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/45.6.859     Document Type: Article

References (18)

1. Jindani, A., Aber, V. R., Edwards, E. A. & Mitchison, D. A. (1980). The early bactericidal activity of drugs in patients with pulmonary tuberculosis. American Review of Respiratory Disease 121, 939-49.
2. Sirgel, F. A., Botha, F. J., Parkin, D. P., Van de Wal, B. W., Donald, P. R., Clark, P. K. et al. (1993). The early bactericidal activity of rifabutin in patients with pulmonary tuberculosis measured by sputum viable counts: a new method of drug assessment. Journal of Antimicrobial Chemotherapy 32, 867-75.
3. Donald, P. R., Sirgel, F. A., Botha, F. J., Seifart, H. I., Parkin, D. P., Vandenplas, M. L. et al. (1997). The early bactericidal activity of isoniazid related to its dose size in pulmonary tuberculosis. American Journal of Respiratory and Critical Care Medicine 156, 895-900.
4. Mitchison, D. A. & Sturm, W. A. (1997). The measurement of early bactericidal activity. In Bailliere's Clinical Infectious Diseases: Mycobacterial Diseases Part II, (Malin, A. & McAdam, K. P. W. J., Eds), pp. 185-206. Bailliere Tindall, London.
5. Mitchison, D. A. (1992). The Garrod Lecture. Understanding the chemotherapy of tuberculosis - current problems. Journal of Antimicrobial Chemotherapy 29, 477-93.
6. Mitchison, D. A. (1993). Assessment of new sterilizing drugs for treating pulmonary tuberculosis by culture at 2 months. American Review of Respiratory Disease 147, 1062-3.
7. Odhiambo, J. A., Borgdorff, M. W., Kiambih, F. M., Kibuga, D. K., Kwamanga, D. O., Ng'ang'a, L. et al. (1999). Tuberculosis and the HIV epidemic: increasing annual risk of tuberculous infection in Kenya, 1986-1996. American Journal of Public Health 89, 1078-82.
8. Galloway, M. R. (1998). Results of the eighth national HIV survey of women attending antenatal clinics of the public health service in South Africa in 1997. AIDS Bulletin (SAMTC) 7, 16-7.
9. Report. (1997). Fourth annual report August 1996 to July 1997. Advisory Council on Aids, Hong Kong.
10. Dean, A. G., Dean, J. A., Coulombier, D., Brendel, K. A., Smith, D. C., Burton, A. H. et al. (1994). Epi Info. Version 6: a word processing, database and statistics program for epidemiology on microcomputers, Centers for Disease Control and Prevention, Atlanta, GA, USA.
11. Mandel, W., Cohn, M. L., Russell, W. F. & Middlebrook, G. (1957). Serum isoniazid levels and catalase activities of tubercle bacilli from isoniazid-treated patients. American Journal of the Medical Sciences 233, 66-8.
12. Mitchison, D. A. (2000). Role of individual drugs in the chemotherapy of tuberculosis. International Journal of Tuberculosis and Lung Disease. 4, 262-7.
13. Tam, C. M., Chan, S. L., Kam, K. M., Sim, E., Staples, D., Sole, K. M. et al. (2000). Rifapentine and isoniazid in the continuation phase of a 6-month regimen. Interim report: no activity of isoniazid in the continuation phase. International Journal of Tuberculosis and Lung Disease. In press.
14. Chan, S. L., Yew, W. W., Ma, W. K., Girling, D. J., Aber, V. R., Felmingham, D. et al. (1992). The early bactericidal activity of rifabutin measured by sputum viable counts in Hong Kong patients with pulmonary tuberculosis. Tubercle and Lung Disease 73, 33-8.
15. Fox, W., Ellard, G. A. & Mitchison, D. A. (1999). Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946-1986, with relevant subsequent publications. Section 1.26.5. International Journal of Tuberculosis and Lung Disease 3, Suppl. 2, S231-S79.
16. Hafner, R., Cohn, J. A., Wright, D. J., Dunlap, N. E., Egorin, M. J., Enama, M. E. et al. (1997). Early bactericidal activity of isoniazid in pulmonary tuberculosis. Optimization of Methodology. The DATRI 008 Study Group. American Journal of Respiratory and Critical Care Medicine 156, 918-23.
17. Sirgel, F. A., Botha, F. J., Parkin, D. P., Van de Wal, B. W., Schall, R., Donald, P. R. et al. (1997). The early bactericidal activity of ciprofloxacin in patients with pulmonary tuberculosis. American Journal of Respiratory and Critical Care Medicine 156, 901-5.
18. Desjardin, L. E., Perkins, M. D., Wolski, K., Haun, S., Teixeira, L., Chen, Y. et al. (1999). Measurement of sputum Mycobacterium tuberculosis messenger RNA as a surrogate for response to chemotherapy. American Journal of Respiratory and Critical Care Medicine 160, 203-10.